⌘K

Home/Filings/4/0001213900-23-045385

4//SEC Filing

Johnson Bankole A. 4

Accession 0001213900-23-045385

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 7:52 AM ET

Size

5.3 KB

Accession

0001213900-23-045385

Insider Transaction Report

Form 4

Period: 2023-05-23

ADIAL PHARMACEUTICALS, INC.ADIL

Johnson Bankole A.

Director10% Owner

Transactions

Award
Stock Option
2023-05-23+40,000→ 40,000 total
Exercise: $0.30From: 2023-05-23Exp: 2033-05-23→ Common Stock (40,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001718158

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 7:52 AM ET
Size: 5.3 KB

View on SEC.gov